Singapore Markets close in 7 hrs 19 mins
Straits Times Index
3,267.07 +11.53 (+0.35%) Nikkei
27,629.85 +111.60 (+0.41%) Hang Seng
20,348.64 +563.99 (+2.85%) FTSE 100
7,484.25 +12.48 (+0.17%) BTC-USD
27,376.52 +229.25 (+0.84%) CMC Crypto 200
600.54 +357.86 (+147.46%)
Orphazyme A/S (DK0060910917.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
At close: 04:18PM CEST
| Previous close | 0.0981 |
| Open | 0.0967 |
| Bid | 0.0900 x N/A |
| Ask | 0.1184 x N/A |
| Day's range | 0.0950 - 0.0967 |
| 52-week range | 0.0950 - 0.0967 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
© 2023 Yahoo. All rights reserved.
